A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Crossover, Placebo-Controlled Pilot Study
New clinical reports have recently been published on tofisopam—an anxiolytic drug currently registered as a benzodiazepine—after a long break in this research area. Neurobiological studies concerning its properties, which differ from those of benzodiazepines, are underway. The analyses presented in...
Váldodahkki: | |
---|---|
Materiálatiipa: | Artihkal |
Giella: | English |
Almmustuhtton: |
MDPI AG
2024-01-01
|
Ráidu: | Pharmaceuticals |
Fáttát: | |
Liŋkkat: | https://www.mdpi.com/1424-8247/17/1/140 |